Trademarks contained herein are the property of Integrated DNA Technologies, Inc. or their respective owners, and may be registered in the USA and/or other jurisdictions. For specific trademark information, see www.idtdna.com/trademarks. For research use only. Not for use in diagnostic procedures...
Shape the future of genomics with IDT. Explore our DNA synthesis platform, innovative genomics research tools, and unmatched customization options.
Integrated DNA Technologies, Inc. (IDT) develops, manufactures, and markets nucleic acid products for the life sciences industry in the areas of academic research, biotechnology, agriculture, medical diagnostics, and pharmaceutical development. The company's primary business is the production of custom ...
Shape the future of genomics with IDT. Explore our DNA synthesis platform, innovative genomics research tools, and unmatched customization options.
Shape the future of genomics with IDT. Explore our DNA synthesis platform, innovative genomics research tools, and unmatched customization options.
北京泽平代理的美国IDT(Integrated DNA Technologies),成立于1987年,2018年成为丹纳赫集团(Danaher Corporation )的一员,30余年来,凭借创新技术研发、先进工艺流程,为生命科学研究、医药开发等前沿研究领域超过118,000名研究者提供了高质量的寡核苷酸定制服务,日均合成>74,000个寡核苷酸、>850个基因和基因片段,每月合成...
英文名称:Integrated DNA Technologies代理 别名:Integrated DNA Technologies上海代理 分子式:Integrated DNA Technologies北京代理 包装规格:Integrated DNA Technologies中国代理 *促销etonbio、polysciences、Mattek、trevigen、Chromogenix、cyguns、IrvineScientific、Innovative Cell Technologies、enzo、novus、immunochemistry、eylabs...
中国上海-11月3日,领先的综合基因解决方案提供商 Integrated DNA Technologies (以下简称“IDT”)在中国上海召开了盛大的开幕启动仪式,宣告了IDT中国公司的正式启航。丹纳赫生命科学中国区的主要领导,IDT核心领导团队,以及来自上海思路迪生物技术有限公司,上海诺捷生物科技有限公司,求臻医学科技(北京)有限公司的嘉宾...
001006282 成立日期: 2009-06-15 企查查编码: QUS1H39XC8 办公地址: 1710 COMMERCIAL PARK CORALVILLE,IA 52401 USA 基本信息 企业注册号 001006282 企业名称 INTEGRATED DNA TECHNOLOGIES, INC. 成立日期 2009-06-15 企业类型 - 注册地 MASSACHUSETTS(马萨诸塞州) ...
“By accessing IDT’s technologies and expertise, we can provide high-quality sequencing data to our clients. This partnership will further us in the journey of novel NGS research and eventually provide cancer researchers with more insights around treatment options.” ...